ProNephro (NGAL) now available through Roche Diagnostics.
✕
August 15, 2025
Q2 INTERIM REPORT PDF
PRESENTATION PDF
WEBCAST RECORDING
May 8, 2025
Q1 INTERIM REPORT PDF
April 11, 2025
March 20, 2025
ANNUAL REPORT 2024 PDF
November 1, 2024
October 22, 2024
August 15, 2024
May 8, 2024
February 22, 2024
April 4, 2024
ANNUAL REPORT 2023 PDF
December 11, 2023
November 1, 2023
AUGUST 1, 2023
May 31, 2023
June 12, 2023
May 10, 2023
May 30, 2023
ANNUAL REPORT 2022 PDF
November 9,2022
August 17, 2022
June 29, 2022
May 11, 2022
April 6, 2022
ANNUAL REPORT 2021 PDF
November 17, 2021
INTERIM REPORT Q3 2021 PDF
INVESTOR MEETINGS Q3 2021 ENG
INVESTOR MEETINGS Q3 2021 DK
August 18, 2021
INTERIM REPORT Q2 2021 PDF
INVESTOR MEETINGS Q2 2021 ENG
INVESTOR MEETINGS Q2 2021 DK
INTERIM REPORT Q1 2021 PDF
INVESTOR MEETINGS Q1 2021 ENG
INVESTOR MEETINGS Q1 2021 DK
March 17, 2021
ANNUAL REPORT 2020 PDF
January 4, 2021
December 15, 2020
November 18, 2020
INTERIM REPORT Q3 2020 PDF
INVESTOR MEETINGS Q3 2020 ENG
INVESTOR MEETINGS Q3 2020 DK
September 15, 2020
HC WAINWRIGHT CONFERENCE PDF
August 19, 2020
INTERIM REPORT Q2 2020 PDF
June 26, 2020
CARLSQUARE SMALL & MID_CAP SEMINAR 2020 PDF
May 7, 2020
INTERIM REPORT Q1 2020 PDF
April 14, 2020
ANNUAL GENERAL MEETING 2020 PDF
March 23, 2020
PRE-EMPTIVE RIGHTS ISSUE PDF
March 11, 2020
ANNUAL REPORT 2019 PDF
December 16, 2019
INTERIM REPORT Q3 2019 PDF
August 15, 2019
INTERIM REPORT Q2 2019 PDF
EXTRAORDINARY GENERAL MEETING 2019 PDF
May 19, 2019
INTERIM REPORT Q1 2019 PDF
March 18, 2019
ANNUAL GENERAL MEETING 2019 PDF
February 22, 2019
ANNUAL REPORT 2018 PDF
January 8, 2019
BIOTECT SHOWCASE 2019 PDF
